Dynavax Technologies Corp [DVAX] stock prices are up 0.68% to $13.42 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DVAX shares have gain 4.68% over the last week, with a monthly amount glided 4.84%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dynavax Technologies Corp [NASDAQ: DVAX] stock has seen the most recent analyst activity on February 11, 2025, when Goldman downgraded its rating to a Sell and also revised its price target to $12 from $15. Previously, Goldman started tracking the stock with Neutral rating on February 01, 2024, and set its price target to $20. On September 27, 2022, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $22 on the stock. Goldman initiated its recommendation with a Buy and recommended $19 as its price target on August 06, 2021. H.C. Wainwright reiterated a Buy rating for this stock on August 07, 2020, and downed its price target to $12. In a note dated August 03, 2020, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $12 to $14.
The stock price of Dynavax Technologies Corp [DVAX] has been fluctuating between $9.74 and $14.05 over the past year. Currently, Wall Street analysts expect the stock to reach $24.5 within the next 12 months. Dynavax Technologies Corp [NASDAQ: DVAX] shares were valued at $13.42 at the most recent close of the market. An investor can expect a potential return of 82.56% based on the average DVAX price forecast.
Analyzing the DVAX fundamentals
The Dynavax Technologies Corp [NASDAQ:DVAX] reported sales of 277.25M for trailing twelve months, representing a surge of 29.56%. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at 0.09%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.20 points at the first support level, and at 12.99 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.58, and for the 2nd resistance point, it is at 13.75.
Ratios To Look Out For
It’s worth pointing out that Dynavax Technologies Corp [NASDAQ:DVAX]’s Current Ratio is 10.80. In addition, the Quick Ratio stands at 9.91 and the Cash Ratio stands at 1.7. Considering the valuation of this stock, the price to sales ratio is 6.01, the price to book ratio is 2.82 and price to earnings (TTM) ratio is 76.82.
Transactions by insiders
Recent insider trading involved CANO FRANCIS, Director, that happened on May 31 ’24 when 3615.0 shares were sold. Chief Accounting Officer, Burgess Justin completed a deal on Mar 01 ’24 to sell 20526.0 shares.
